Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to to compare steady-state total
growth hormone (GH) exposure in haemodialysis (HD) patients with that of matched healthy
subjects.